Towerview LLC grew its holdings in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 436,873 shares of the company’s stock after buying an additional 94,395 shares during the quarter. […]
Towerview LLC boosted its holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 27.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 436,873 shares of the company’s stock after purchasing an additional 94,395 shares during the period. Corvus Pharmaceuticals accounts for approximately 0.5% of Towerview LLC’s portfolio, making the stock its 17th […]
Towerview LLC Has $500,000 Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Towerview LLC Has $500,000 Stock Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) Director Linda Grais bought 10,000 shares of the stock in a transaction that occurred on Monday, May 15th. The shares were bought at an average cost of $2.45 per share, with a total value of $24,500.00. Following the completion of the transaction, the director now owns 10,000 shares […]